Skip to main content
OpenTrials
Completed

NCT Number: NCT06205394

Improving The Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors, Intended for SGM Study

This study evaluates Improving the Breast Cancer Care Delivery Model for Sex and Gender Minority (INTENDED for SGM) in identifying the patient, support person and provider barriers to quality care in SGM breast/chest cancer survivors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Carcinoma Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

About this study

PRIMARY OBJECTIVE:

I. To determine the important ways the iCanDecide breast cancer decision aid needs revised for SGM people, and how best to integrate a culturally-relevant tool into clinical practice.

OUTLINE: This is an observational study.

AIM 1: Interview transcripts from SANGRIA study utilized to explore the values, preferences and key considerations for breast cancer treatment decision making in SGM individuals.

AIM 2: Patients are assigned to 1 of 2 groups.

GROUP 1: Cancer survivors participate in a focus group on study.

GROUP 2: Breast cancer clinicians undergo a semi-structured interview on study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • SURVIVORS:
  • Self-identify as a member of the sex and gender minority community or partner with an individual of the same sex or gender
  • Must be a breast cancer survivor, in active treatment or completed active treatment in the last 10 years (not including hormone therapy)
  • Be over age 18
  • English-speaking
  • Received care in the US

BREAST ONCOLOGY CLINICIANS: Physicians, advanced practice providers, nurses, psychologists and social workers will be eligible if they:

  • Provide care and/or surgical decision support to individuals diagnosed with early stage breast cancer in the US
  • Are English-speaking

Treatment and study plan

Non-Interventional Study

Other

Non-interventional study

Primary outcomes

  1. Survivor participant feedback, opinions, and preferences for breast cancer care

    Time frame: At completion of study up to 2 years

    Data is verbally reported and collected in focus groups

  2. Clinician participant reports of experiences, opinions, and knowledge of caring for LGBTQ+ people

    Time frame: At completion of study up to 2 years

    Data is verbally reported and collected in interviews

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

Improving the Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors (Intended for SGM)

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 16, 2024
Registry last updated
Jan 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.